The FDA has issued a recall for certain eye drops after receiving a consumer complaint.


December 26, 2024 Tags:

Systane Lubricant Eye Drops have been voluntarily recalled following a discovery of possible fungal contamination, the U.S. Food and Drug Administration (FDA) announced. The recall affects one batch of the product, specifically the Systane Lubricant Eye Drops Ultra PF, which were sold in single-use vials. The decision to recall the product was prompted by a consumer complaint about foreign material found inside one of the sealed vials.
The FDA's investigation revealed that the foreign material in question was fungal in nature, leading to the decision to pull the affected lot from the market. This fungal contamination presents a serious risk to users, especially those with weakened immune systems. If the contaminated drops are used, they could potentially cause eye infections that might result in vision loss or, in very rare cases, even be life-threatening for individuals with compromised immune systems.

Alcon Laboratories, the company responsible for manufacturing the Systane eye drops, has emphasized that there have been no reports of adverse effects or illnesses linked to the product thus far. The company reassured the public that the contamination appeared to be isolated to the single vial returned by a customer, and the recall was issued as a precautionary measure to prioritize the safety of consumers.

The affected batch of Systane eye drops comes in a 25-count package of on-the-go single-use vials. These vials have a lot number of 10101 and an expiration date of September 2025. The product was sold primarily at Publix grocery stores, which has issued a notice about the recall.

Systane eye drops are commonly used to treat dryness and irritation in the eyes, providing relief from the burning and discomfort that often accompanies dry eye symptoms. They are typically sold in small, portable vials for convenience, especially for people who need to manage their dry eye condition while on the go.

Consumers who have purchased the recalled product are urged to stop using it immediately. They can return the product to the place of purchase for a refund or replacement. The FDA also advises that anyone who has used the recalled eye drops and is experiencing symptoms, such as eye discomfort or irritation, should seek medical attention from a healthcare provider promptly.

Alcon, in response to the recall, assured that it is conducting an ongoing investigation to understand the root cause of the contamination. However, they stated that the foreign material seems to be limited to the single unit that was returned. As a result, the company took the necessary step to recall the affected batch out of an abundance of caution, ensuring that the safety and well-being of consumers remain a top priority.

The recall of Systane eye drops highlights the importance of vigilance when it comes to product safety, particularly for items that come in direct contact with sensitive areas like the eyes. While the recall seems to be isolated to a specific lot, it serves as a reminder to consumers to always check product labels and lot numbers, especially in the case of medical products.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

You may also like

CDC Warns Travelers of Polio Risk Before Trips to Spain, UK and Other Countries

International travel plans often come with reminders about passports, visas, and safety precautions. Now, health officials are urging travelers to....

Julie Drolet Returns to Airwaves After Cancer Battle, Embracing a Renewed Purpose

Julie Drolet is stepping back into the newsroom after a long and difficult absence.The respected journalist returns to Radio-Canada’s Téléjournal....

Health Canada Faces Pressure to Mandate Labels on Gene-Edited Pork

A growing coalition of farm and environmental groups is urging Health Canada to require clear labels on pork from gene-edited....

Alberta to Invest $7.7B to Boost Physician Recruitment

Alberta government has announced a record $7.7-billion health-care investment aimed at strengthening physician recruitment, training, and compensation in its 2026–27....

Canada Opens National Survey to Shape First Men’s Health Strategy

The federal government has taken its first formal step toward a nationwide men’s health strategy, announcing a countrywide public survey....

Birth Control Pill Recall in Canada After Packaging Error Raises Pregnancy Risk

A packaging defect has triggered a recall of two commonly prescribed birth control pills in Canada, after a user discovered....

Historic Stigma Deters Black Quebecers From Giving Blood

Stanley Étienne rolls up his sleeve without hesitation. The 41-year-old Montreal bus driver has donated blood 37 times in recent....

134 out of 560 Operating Rooms Sit Idle in Quebec Amid Shortage

Quebec’s hospital network currently has 134 operating rooms closed out of 560 across the province, raising concerns about surgical delays....

Measles Outbreak Linked to Farm Show Prompts Action

Manitoba health officials have confirmed that more than 30 measles cases have links to a major agricultural event held last....

Blood Pressure Medication Recall Raises Safety Alert Across Canada

A nationwide blood pressure medication recall has prompted Health Canada to urge patients to check their prescriptions carefully.The alert follows....

Brain Exercise Dementia Risk Reduced by 25%, Long-Term Study Suggests

A simple brain exercise may significantly lower dementia risk, according to a major long-term study released this week.Researchers found that....

US Births Decline in 2025 After Brief Rise in 2024

A slight decline in U.S. births last year is raising fresh questions about whether the modest increase recorded in 2024....